E7 TCR T Cells With or Without PD-1 Blockade for Human Papillomavirus-Associated Cancers

Conditions:   Cervical Cancer;   Vaginal Cancer;   Anal Cancer;   Penile Cancer;   Oropharyngeal Cancer
Interventions:   Biological: E7 TCR cells;   Drug: pembrolizumab;   Drug: aldesleukin;   Drug: fludarabine;   Drug: cyclophosphamide
Sponsor:   National Cancer Institute (NCI)
Recruiting - verified August 2016

from #ORL via xlomafota13 on Inoreader http://ift.tt/2b7PbrI
via IFTTT